Safety and Effectiveness of a Novel Integrated Angiography System for Continuous Guidance and Flushing in Diagnostic Cerebral Catheter Angiography: A Randomized Controlled Trial.
Boseong Kwon, Jong-Tae Yoon, Yun Hyeok Choi, Soo Jeong, Byung Jun Kim, Joon Ho Choi, Sun Moon Hwang, Deok Hee Lee, Yunsun Song
{"title":"Safety and Effectiveness of a Novel Integrated Angiography System for Continuous Guidance and Flushing in Diagnostic Cerebral Catheter Angiography: A Randomized Controlled Trial.","authors":"Boseong Kwon, Jong-Tae Yoon, Yun Hyeok Choi, Soo Jeong, Byung Jun Kim, Joon Ho Choi, Sun Moon Hwang, Deok Hee Lee, Yunsun Song","doi":"10.3174/ajnr.A8700","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>The guided angiography system, an integrated angiography system, enables continuous guidance and flushing during diagnostic procedures. A guidewire provides guidance by remaining inside the catheter during contrast injection into tortuous vessels. While its feasibility was demonstrated in a retrospective study, this randomized controlled trial aims to evaluate its safety and effectiveness.</p><p><strong>Materials and methods: </strong>This single-center, single-blind, randomized controlled trial was conducted from September 2021 to June 2022. Patients with unruptured intracranial aneurysms were enrolled and randomly assigned to either the guided or the conventional group. Primary outcomes were procedure time and serious adverse events. Secondary outcomes included catheterization success, adverse events, fluoroscopy time, fluoroscopy dose, and image quality.</p><p><strong>Results: </strong>A total of 200 participants (mean age 59 ± 10 years, 71% women) were randomized into the guided (n = 100) and the conventional (n = 100) groups. The guided group demonstrated shorter procedure times compared to the conventional group (18.3 ±9.2 min vs. 21.3 ± 8.1 min, <i>P</i> < .001). There were no serious adverse events in either group, and adverse event rates were similar. Catheterization success rates were similar between the guided and conventional groups (93.9% vs. 96.8%, <i>P</i> = .226). However, the guided angiography system backed up more catheterization failures from the conventional angiography system, but not vice versa (57.1% vs. 11.1%, <i>P</i> = .003). Among catheterization successes, the guided group achieved shorter fluoroscopy time (7.0 min vs. 7.7 min, <i>P</i> = .033) and lower fluoroscopy dose (466.8 μGy·m<sup>2</sup> vs. 566.5 μGy·m<sup>2</sup>, <i>P</i> = .015). Regarding imaging quality, clinical acceptability was comparable between the guided and conventional groups (95.3% vs. 95.5%, <i>P</i> = .781).</p><p><strong>Conclusions: </strong>The guided angiography system offers a simple and effective alternative for diagnostic cerebral catheter angiography, with reduced radiation exposure and a favorable safety profile.</p><p><strong>Abbreviations: </strong>AE = adverse events; Fr = French.</p>","PeriodicalId":93863,"journal":{"name":"AJNR. American journal of neuroradiology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AJNR. American journal of neuroradiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3174/ajnr.A8700","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background and purpose: The guided angiography system, an integrated angiography system, enables continuous guidance and flushing during diagnostic procedures. A guidewire provides guidance by remaining inside the catheter during contrast injection into tortuous vessels. While its feasibility was demonstrated in a retrospective study, this randomized controlled trial aims to evaluate its safety and effectiveness.
Materials and methods: This single-center, single-blind, randomized controlled trial was conducted from September 2021 to June 2022. Patients with unruptured intracranial aneurysms were enrolled and randomly assigned to either the guided or the conventional group. Primary outcomes were procedure time and serious adverse events. Secondary outcomes included catheterization success, adverse events, fluoroscopy time, fluoroscopy dose, and image quality.
Results: A total of 200 participants (mean age 59 ± 10 years, 71% women) were randomized into the guided (n = 100) and the conventional (n = 100) groups. The guided group demonstrated shorter procedure times compared to the conventional group (18.3 ±9.2 min vs. 21.3 ± 8.1 min, P < .001). There were no serious adverse events in either group, and adverse event rates were similar. Catheterization success rates were similar between the guided and conventional groups (93.9% vs. 96.8%, P = .226). However, the guided angiography system backed up more catheterization failures from the conventional angiography system, but not vice versa (57.1% vs. 11.1%, P = .003). Among catheterization successes, the guided group achieved shorter fluoroscopy time (7.0 min vs. 7.7 min, P = .033) and lower fluoroscopy dose (466.8 μGy·m2 vs. 566.5 μGy·m2, P = .015). Regarding imaging quality, clinical acceptability was comparable between the guided and conventional groups (95.3% vs. 95.5%, P = .781).
Conclusions: The guided angiography system offers a simple and effective alternative for diagnostic cerebral catheter angiography, with reduced radiation exposure and a favorable safety profile.